Records containing: Osteosarcoma Recurrent
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-14Single-arm Open-label Phase I/II Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
-
CLINICAL_TRIALS study record update · 2026-03-02Study of Tegavivint, a Transducin Beta-like Protein 1 (TBL1) Inhibitor, With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
-
CLINICAL_TRIALS study record update · 2026-02-25Phase II Trial of Olaparib in Combination With Ceralasertib in Patients With Recurrent Osteosarcoma
-
CLINICAL_TRIALS study record update · 2026-02-05A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination With Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
-
CLINICAL_TRIALS study record update · 2025-10-31SARC038: A Phase 2 Study of Regorafenib in Combination With Nivolumab in Patients With Refractory or Recurrent Osteosarcoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-11DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
-
CLINICAL_TRIALS study record update · 2023-05-25A Multicentre, Retrospective, Observational Study to Analyse the Efficacy of High Dose Isofosfamide Administered Through Elastomer in Patients With Relapsed/ Refractory Osteosarcoma
-
CLINICAL_TRIALS study record update · 2021-11-26A Retrospective Observational Study of the Effectiveness of Gemcitabine -Docetaxel in Patients With Relapsed Osteosarcoma Who Have Been Treated With HD-IFO in First Line Treatment